—
C+
C+ The full Closelook — membership. Open the C+ overview

Crispr Therapeutics AG (CRSP) — Technical state

As of 2026-09-18 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Recovery attempt under the 200-day

Trades +6.7% vs the 50-day and +6.1% vs the 200-day average, 27.9% below the 52-week high and +28.2% off the 52-week low; a death cross printed 4 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the CRSP chart & overview · the signal board

FAQ · from the current data · as of 2026-09-18

Quick answers

What is the current Closelook signal on CRSP?

Recovery attempt under the 200-day — Trades +6.7% vs the 50-day and +6.1% vs the 200-day average, 27.9% below the 52-week high and +28.2% off the 52-week low; a death cross printed 4 sessions ago. Computed from daily closes. As of 2026-09-18; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is CRSP above its 50-day and 200-day moving averages?

As of 2026-09-18, Crispr Therapeutics AG trades +6.7% above its 50-day and +6.1% above its 200-day average, with the 20-day +1% away.

How far is CRSP from its 52-week high?

27.9% below the 52-week high and 28.2% above the 52-week low, as of 2026-09-18.

Mentioned on Closelook

Where CRSP appears in the diary — 2 pieces, newest first. Every link is our own writing.

Long reads

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.